This is a preview of subscription content, log in via an institution to check access.
Reference
Romiti R, et al. Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: Integrated safety analysis from 11 clinical trials of patients with plaque psoriasis. British Journal of Dermatology : 4 Jan 2019. Available from: URL: http://doi.org/10.1111/bjd.17604
Rights and permissions
About this article
Cite this article
Latent tuberculosis in ixekizumab clinical trial participants. Reactions Weekly 1736, 10 (2019). https://doi.org/10.1007/s40278-019-56905-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-56905-x